PIN90 HEALTH-ECONOMIC MODELLING TO INFORM PRIVATE SECTOR INVESTMENT IN INFECTIOUS DISEASE TREATMENTS IN MIDDLE-INCOME COUNTRIES: THE CASE OF TUBERCULOSIS

This article reflects on current trends and proposes new considerations for the future of mobile technologies for health (mHealth). Our focus is predominantly on the value of and concerns with regard to the application of digital health within low- and middle-income countries (LMICs). It is in LMICs and marginalized communities that mHealth (within the wider scope of digital health) could be most useful and valuable. Peer-reviewed literature on mHealth in LMICs provides reassurance of this potential, often reflecting on the ubiquity of mobile phones and ever-increasing connectivity globally, reaching remote or otherwise disengaged populations. Efforts to adapt successful programs for LMIC contexts and populations are only just starting to reap rewards. Private-sector investment in mHealth offers value through enhanced capacity and advances in technology as well as the ability to meet increasing consumer demand for real-time, accessible, convenient, and choice-driven health care options. We examine some of the potential considerations associated with a private-sector investment, questioning whether a core of transparency, local ownership, equity, and safety are likely to be upheld in the current environment of health entrepreneurship. Expected final online publication date for the Annual Review of Public Health, Volume 43 is April 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

Download Full-text

PIN132 HEALTH-ECONOMIC MODELLING OF INFECTIOUS DISEASE DIAGNOSTICS: CURRENT APPROACHES AND FUTURE OPPORTUNITIES

Value in Health ◽

10.1016/j.jval.2019.09.1373 ◽

2019 ◽

Vol 22 ◽

pp. S660

Author(s):

S. Van der Pol ◽

P. Rojas ◽

C. Juárez ◽

A.D.I. van Asselt ◽

F. Antoñanzas ◽

...

Keyword(s):

Infectious Disease ◽

Health Economic ◽

Economic Modelling ◽

Disease Diagnostics ◽

Infectious Disease Diagnostics ◽

Health Economic Modelling

Download Full-text

Hospitals’ responsibility in response to the threat of infectious disease outbreak in the context of the coronavirus disease 2019 (COVID-19) pandemic: Implications for low- and middle-income countries

Global Health Journal ◽

10.1016/j.glohj.2020.11.005 ◽

2020 ◽

Vol 4 (4) ◽

pp. 113-117

Author(s):

Ji Zhang ◽

Xinpu Lu ◽

Yinzi Jin ◽

Zhi-Jie Zheng

Keyword(s):

Infectious Disease ◽

Disease Outbreak ◽

Infectious Disease Outbreak ◽

Middle Income ◽

Middle Income Countries ◽

Low And Middle Income

Download Full-text

Early health economic modelling of single-stage cartilage repair. Guiding implementation of technologies in regenerative medicine

Journal of Tissue Engineering and Regenerative Medicine ◽

10.1002/term.2197 ◽

2016 ◽

Vol 11 (10) ◽

pp. 2950-2959 ◽

Cited By ~ 11

Author(s):

Tommy S. de Windt ◽

Juliette C. Sorel ◽

Lucienne A. Vonk ◽

Michelle M. A. Kip ◽

Maarten J. Ijzerman ◽

...

Keyword(s):

Health Economic ◽

Regenerative Medicine ◽

Cartilage Repair ◽

Single Stage ◽

Economic Modelling ◽

Early Health ◽

Health Economic Modelling

Download Full-text

Private sector, for-profit health providers in low and middle income countries: can they reach the poor at scale?

Globalization and Health ◽

10.1186/1744-8603-10-52 ◽

2014 ◽

Vol 10 (1) ◽

pp. 52 ◽

Cited By ~ 9

Author(s):

Elizabeth Tung ◽

Sara Bennett

Keyword(s):

Private Sector ◽

Health Providers ◽

Middle Income ◽

For Profit ◽

Middle Income Countries ◽

The Poor ◽

Low And Middle Income

Download Full-text

Outcomes of HIV treatment from the private sector in low-income and middle-income countries: a systematic review protocol

BMJ Open ◽

10.1136/bmjopen-2019-031844 ◽

2020 ◽

Vol 10 (1) ◽

pp. e031844

Author(s):

Gitau Mburu ◽

Ewemade Igbinedion ◽

Sin How Lim ◽

Aung Zayar Paing ◽

Siyan Yi ◽

...

Keyword(s):

Systematic Review ◽

Private Sector ◽

Clinical Outcomes ◽

Low Income ◽

Hiv Treatment ◽

Future Research ◽

Publication Date ◽

Middle Income ◽

Middle Income Countries ◽

Secondary Outcomes

IntroductionPrivate sector provision of HIV treatment is increasing in low-income and middle-income countries (LMIC). However, there is limited documentation of its outcomes. This protocol reports a proposed systematic review that will synthesise clinical outcomes of private sector HIV treatment in LMIC.Methods and analysisThis review will be conducted in accordance with the preferred reporting items for systematic review and meta-analyses protocols. Primary outcomes will include: (1) proportion of eligible patients initiating antiretroviral therapy (ART); (2) proportion of those on ART with <1000 copies/mL; (3) rate of all-cause mortality among ART recipients. Secondary outcomes will include: (1) proportion receivingPneumocystis jirovecipneumonia prophylaxis; (2) proportion with >90% ART adherence (based on any measure reported); (3) proportion screened for non-communicable diseases (specifically cervical cancer, diabetes, hypertension and mental ill health); (iv) proportion screened for tuberculosis. A search of five electronic bibliographical databases (Embase, Medline, PsychINFO, Web of Science and CINAHL) and reference lists of included articles will be conducted to identify relevant articles reporting HIV clinical outcomes. Searches will be limited to LMIC. No age, publication date, study-design or language limits will be applied. Authors of relevant studies will be contacted for clarification. Two reviewers will independently screen citations and abstracts, identify full text articles for inclusion, extract data and appraise the quality and bias of included studies. Outcome data will be pooled to generate aggregative proportions of primary and secondary outcomes. Descriptive statistics and a narrative synthesis will be presented. Heterogeneity and sensitivity assessments will be conducted to aid interpretation of results.Ethics and disseminationThe results of this review will be disseminated through a peer-reviewed scientific manuscript and at international scientific conferences. Results will inform quality improvement strategies, replication of identified good practices, potential policy changes, and future research.PROSPERO registration numberCRD42016040053.

Download Full-text

It’s Not the Model, It’s the Way You Use It: Exploratory Early Health Economics Amid Complexity Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling"

International Journal of Health Policy and Management ◽

10.15171/ijhpm.2020.04 ◽

2020 ◽

Cited By ~ 1

Author(s):

Andrew Partington ◽

Jonathan Karnon

Keyword(s):

Health Economic ◽

Complex Interventions ◽

Healthcare Services ◽

Economic Modelling ◽

Learning And Development ◽

Health Technologies ◽

Significant Disagreement ◽

Early Health ◽

Health Economic Modelling

In a review recently published in this journal, Grutters et al outline the scope and impact of their early health economic modelling of healthcare innovations. Their reflections shed light on ways that health economists can shift-away from traditional reimbursement decision-support, towards a broader role of facilitating the exploration of existing care pathways, and the design of options to implement or discontinue healthcare services. This is a crucial role in organisations that face constant pressure to react and adapt with changes to their existing service configurations, but where there may exist significant disagreement and uncertainty on the extent to which change is warranted. Such dynamics are known to create complex implementation environments, where changes risk being poorly implemented or fail to be sustained. In this commentary, we extend the discussion by Grutters et al on early health economic modelling, to the evaluation of complex interventions and systems. We highlight how early health economic modelling can contribute to a participatory approach for ongoing learning and development within healthcare organisations.

Download Full-text